Retatrutide is a new pharmaceutical in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in research studies. By activating these receptors, Retatrutide reduces hunger pangs, {promotesglucose regulation, and ultimately contributes to significant weight loss. While f